business
Lantheus stock holds at Market Outperform despite FDA setback
Lantheus stock holds at Market Outperform despite FDA setback
Read full story on Investing.com → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop